4.7 Review

The Functional Role of Lipoproteins in Atherosclerosis: Novel Directions for Diagnosis and Targeting Therapy

期刊

AGING AND DISEASE
卷 13, 期 2, 页码 491-520

出版社

INT SOC AGING & DISEASE
DOI: 10.14336/AD.2021.0929

关键词

atherosclerosis; dyslipidemia; lipoproteins; HDL; LDL

资金

  1. National Nature Science Foundation of China [81800267, 81870328, 82170281, U2004203]
  2. Henan Medical Science and Technology Joint Building Program [2018020002]
  3. Henan Thousand Talents Program [ZYQR201912131]
  4. Henan Province Youth Talent Promoting Project [2020HYTP051]
  5. Excellent Youth Science Foundation of Henan Province [202300410362]
  6. University of Otago Health Science Postdoctoral Fellowship
  7. New Zealand Ministry of Business, Innovation and Employment (MBIE) Science Whitinga Fellowship [21-UOO-006]
  8. National Heart Foundation of New Zealand [1891, 1896]
  9. New Zealand Health Research Council [19/779]

向作者/读者索取更多资源

Dyslipidemia increases the risk of atherosclerosis, and lipoproteins play a significant role in its development. Understanding lipoprotein function can help predict risk and provide novel treatment approaches for atherosclerosis.
Dyslipidemia, characterized by a high level of lipids (cholesterol, triglycerides, or both), can increase the risk of developing and progressing atherosclerosis. As atherosclerosis progresses, the number and severity of aterial plagues increases with greater risk of myocardial infarction, a major contributor to cardiovascular mortality. Atherosclerosis progresses in four phases, namely endothelial dysfunction, fatty streak formation, lesion progression and plaque rupture, and eventually thrombosis and arterial obstruction. With greater understanding of the pathological processes underlying atherosclerosis, researchers have identified that lipoproteins play a significant role in the development of atherosclerosis. In particular, apolipoprotein B (apoB)-containing lipoproteins have been shown to associate with atherosclerosis. Oxidized low-density lipoproteins (ox-LDLs) also contribute to the progression of atherosclerosis whereas high-density lipoproteins (HDL) contribute to the removal of cholesterol from macrophages thereby inhibiting the formation of foam cells. Given these known associations, lipoproteins may have potential as biomarkers for predicting risk associated with atherosclerotic plaques or may be targets as novel therapeutic agents. As such, the rapid development of drugs targeting lipoprotein metabolism may lead to novel treatments for atherosclerosis. A comprehensive review of lipoprotein function and their role in atherosclerosis, along with the latest development of lipoprotein targeted treatment, is timely. This review focuses on the functions of different lipoproteins and their involvement in atherosclerosis. Further, diagnostic and therapeutic potential are highlighted giving insight into novel lipoprotein-targetted approaches to treat atherosclerosis.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据